Next up in our series of #pledgeforpatients is Eva Essig, Intellia’s Vice President of Regulatory Affairs. Eva’s pledge focuses on the potential of what science can do not only for patients themselves, but more broadly as a whole. #CRISPR #genomeediting https://t.co/0zOff098lf